AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie pPI: Pharmaceutical Preparation Manufacturing (Index Dec 1981=100)
FRED (PCU325412325412)
Latest, FY2025
916.70
Period ended Dec 31, 2025
Change on a year earlier
+0.3%
914.40 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (PCU325412325412)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PPI: Pharmaceutical Preparation Manufacturing (Index Dec 1981=100) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 916.70 | +0.3% | FRED (PCU325412325412) ↗ |
| FY2024 | Dec 31, 2024 | 914.40 | +2.2% | FRED (PCU325412325412) ↗ |
| FY2023 | Dec 31, 2023 | 894.70 | +4.0% | FRED (PCU325412325412) ↗ |
| FY2022 | Dec 31, 2022 | 860.50 | +3.2% | FRED (PCU325412325412) ↗ |
| FY2021 | Dec 31, 2021 | 834.00 | +1.3% | FRED (PCU325412325412) ↗ |
| FY2020 | Dec 31, 2020 | 823.60 | +1.5% | FRED (PCU325412325412) ↗ |
| FY2019 | Dec 31, 2019 | 811.10 | +3.1% | FRED (PCU325412325412) ↗ |
| FY2018 | Dec 31, 2018 | 786.80 | +4.1% | FRED (PCU325412325412) ↗ |
| FY2017 | Dec 31, 2017 | 756.10 | +5.9% | FRED (PCU325412325412) ↗ |
| FY2016 | Dec 31, 2016 | 714.10 | – | FRED (PCU325412325412) ↗ |
Cite this data
StockData. (2026). AbbVie PPI: Pharmaceutical Preparation Manufacturing (Index Dec 1981=100), annual FY2016–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fred_ppi_pharma
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.